Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.
Stellbrink HJ, Orkin C, Arribas JR, Compston J, Gerstoft J, Van Wijngaerden E, Lazzarin A, Rizzardini G, Sprenger HG, Lambert J, Sture G, Leather D, Hughes S, Zucchi P, Pearce H; ASSERT Study Group.
Stellbrink HJ, et al.
Clin Infect Dis. 2010 Oct 15;51(8):963-72. doi: 10.1086/656417.
Clin Infect Dis. 2010.
PMID: 20828304
Clinical Trial.